ID   FGFR4_RAT               Reviewed;         800 AA.
AC   Q498D6;
DT   21-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   02-OCT-2024, entry version 146.
DE   RecName: Full=Fibroblast growth factor receptor 4;
DE            Short=FGFR-4;
DE            EC=2.7.10.1;
DE   AltName: CD_antigen=CD334;
DE   Flags: Precursor;
GN   Name=Fgfr4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   FUNCTION AS FGF19 RECEPTOR.
RX   PubMed=17623664; DOI=10.1074/jbc.m704165200;
RA   Kurosu H., Choi M., Ogawa Y., Dickson A.S., Goetz R., Eliseenkova A.V.,
RA   Mohammadi M., Rosenblatt K.P., Kliewer S.A., Kuro-o M.;
RT   "Tissue-specific expression of betaKlotho and fibroblast growth factor
RT   (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.";
RL   J. Biol. Chem. 282:26687-26695(2007).
CC   -!- FUNCTION: Tyrosine-protein kinase that acts as a cell-surface receptor
CC       for fibroblast growth factors and plays a role in the regulation of
CC       cell proliferation, differentiation and migration, and in regulation of
CC       lipid metabolism, bile acid biosynthesis, glucose uptake, vitamin D
CC       metabolism and phosphate homeostasis. Required for normal down-
CC       regulation of the expression of CYP7A1, the rate-limiting enzyme in
CC       bile acid synthesis, in response to FGF19. Phosphorylates PLCG1 and
CC       FRS2. Ligand binding leads to the activation of several signaling
CC       cascades. Activation of PLCG1 leads to the production of the cellular
CC       signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate.
CC       Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and
CC       SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the
CC       MAP kinase signaling pathway, as well as of the AKT1 signaling pathway.
CC       Promotes SRC-dependent phosphorylation of the matrix protease MMP14 and
CC       its lysosomal degradation. FGFR4 signaling is down-regulated by
CC       receptor internalization and degradation; MMP14 promotes
CC       internalization and degradation of FGFR4 (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:17623664}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Present in an inactive conformation in the absence
CC       of bound ligand. Ligand binding leads to dimerization and activation by
CC       autophosphorylation on tyrosine residues (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Homodimer after ligand binding. Interacts with FGF1,
CC       FGF2, FGF4, FGF6, FGF8, FGF9, FGF16, FGF17, FGF18, FGF19, FGF21 and
CC       FGF23 (in vitro). Binding affinity for FGF family members is enhanced
CC       by interactions between FGFs and heparan sulfate proteoglycans.
CC       Interacts with KLB; this strongly increases the affinity for FGF19 and
CC       FGF23. Affinity for FGF19 is strongly increased by KLB and sulfated
CC       glycosaminoglycans. KLB and KL both interact with the core-glycosylated
CC       FGFR4 in the endoplasmic reticulum and promote its degradation, so that
CC       only FGFR4 with fully mature N-glycans is expressed at the cell
CC       surface. Identified in a complex with NCAM1, CDH2, PLCG1, FRS2, SRC,
CC       SHC1, GAP43 and CTTN. Interacts with MMP14 and HIP1. Interacts with
CC       STAT3 (By similarity). {ECO:0000250|UniProtKB:P22455}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endosome {ECO:0000250}. Endoplasmic reticulum {ECO:0000250}.
CC       Note=Internalized from the cell membrane to recycling endosomes, and
CC       from there back to the cell membrane. {ECO:0000250}.
CC   -!- PTM: N-glycosylated. Full maturation of the glycan chains in the Golgi
CC       is essential for high affinity interaction with FGF19 (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. Subject to proteasomal degradation when not fully
CC       glycosylated (By similarity). {ECO:0000250}.
CC   -!- PTM: Autophosphorylated. Binding of FGF family members together with
CC       heparan sulfate proteoglycan or heparin promotes receptor dimerization
CC       and autophosphorylation on tyrosine residues. Autophosphorylation
CC       occurs in trans between the two FGFR molecules present in the dimer (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Fibroblast growth factor receptor subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC100260; AAI00261.1; -; mRNA.
DR   RefSeq; NP_001103374.1; NM_001109904.1.
DR   AlphaFoldDB; Q498D6; -.
DR   SMR; Q498D6; -.
DR   STRING; 10116.ENSRNOP00000069871; -.
DR   BindingDB; Q498D6; -.
DR   ChEMBL; CHEMBL4802008; -.
DR   GlyCosmos; Q498D6; 4 sites, No reported glycans.
DR   GlyGen; Q498D6; 4 sites.
DR   iPTMnet; Q498D6; -.
DR   PhosphoSitePlus; Q498D6; -.
DR   jPOST; Q498D6; -.
DR   PaxDb; 10116-ENSRNOP00000050988; -.
DR   ABCD; Q498D6; 1 sequenced antibody.
DR   GeneID; 25114; -.
DR   KEGG; rno:25114; -.
DR   UCSC; RGD:2612; rat.
DR   AGR; RGD:2612; -.
DR   CTD; 2264; -.
DR   RGD; 2612; Fgfr4.
DR   VEuPathDB; HostDB:ENSRNOG00000016763; -.
DR   eggNOG; KOG0200; Eukaryota.
DR   HOGENOM; CLU_000288_74_3_1; -.
DR   InParanoid; Q498D6; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; Q498D6; -.
DR   TreeFam; TF316307; -.
DR   Reactome; R-RNO-109704; PI3K Cascade.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1307965; betaKlotho-mediated ligand binding.
DR   Reactome; R-RNO-190322; FGFR4 ligand binding and activation.
DR   Reactome; R-RNO-5654228; Phospholipase C-mediated cascade, FGFR4.
DR   Reactome; R-RNO-5654712; FRS-mediated FGFR4 signaling.
DR   Reactome; R-RNO-5654719; SHC-mediated cascade:FGFR4.
DR   Reactome; R-RNO-5654720; PI-3K cascade:FGFR4.
DR   Reactome; R-RNO-5654733; Negative regulation of FGFR4 signaling.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   PRO; PR:Q498D6; -.
DR   Proteomes; UP000002494; Chromosome 17.
DR   Bgee; ENSRNOG00000016763; Expressed in lung and 15 other cell types or tissues.
DR   GO; GO:0005911; C:cell-cell junction; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005768; C:endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0030133; C:transport vesicle; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0017134; F:fibroblast growth factor binding; ISS:UniProtKB.
DR   GO; GO:0005007; F:fibroblast growth factor receptor activity; IPI:MGI.
DR   GO; GO:0008201; F:heparin binding; ISS:UniProtKB.
DR   GO; GO:0061144; P:alveolar secondary septum development; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0042632; P:cholesterol homeostasis; ISS:UniProtKB.
DR   GO; GO:0008543; P:fibroblast growth factor receptor signaling pathway; IPI:MGI.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0030324; P:lung development; ISO:RGD.
DR   GO; GO:0090272; P:negative regulation of fibroblast growth factor production; ISO:RGD.
DR   GO; GO:0010629; P:negative regulation of gene expression; ISO:RGD.
DR   GO; GO:0001759; P:organ induction; ISO:RGD.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0055062; P:phosphate ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0043085; P:positive regulation of catalytic activity; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:2000573; P:positive regulation of DNA biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:2000830; P:positive regulation of parathyroid hormone secretion; ISO:RGD.
DR   GO; GO:0045862; P:positive regulation of proteolysis; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0070857; P:regulation of bile acid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0010715; P:regulation of extracellular matrix disassembly; ISS:UniProtKB.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; ISS:UniProtKB.
DR   GO; GO:0010966; P:regulation of phosphate transport; ISO:RGD.
DR   GO; GO:0051174; P:regulation of phosphorus metabolic process; ISO:RGD.
DR   GO; GO:0070640; P:vitamin D3 metabolic process; ISO:RGD.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 3.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR016248; FGF_rcpt_fam.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   PANTHER; PTHR24416:SF343; FIBROBLAST GROWTH FACTOR RECEPTOR 4; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF13927; Ig_3; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PIRSF; PIRSF000628; FGFR; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 3.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50835; IG_LIKE; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Disulfide bond; Endoplasmic reticulum;
KW   Endosome; Glycoprotein; Immunoglobulin domain; Kinase; Membrane;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000255"
FT   CHAIN           17..800
FT                   /note="Fibroblast growth factor receptor 4"
FT                   /id="PRO_0000227548"
FT   TOPO_DOM        17..367
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        368..388
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        389..800
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          17..115
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          148..236
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          245..345
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          465..753
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          768..800
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        610
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         471..479
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         501
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         571
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P22455"
FT   MOD_RES         640
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P22455"
FT   MOD_RES         641
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P22455"
FT   MOD_RES         752
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P22455"
FT   CARBOHYD        109
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        254
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        286
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        307
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        54..98
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        168..220
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        267..329
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   800 AA;  88708 MW;  4D3CF9C152C9A4EE CRC64;
     MWLLLALLSI FQETPAFSLE ASEEMEQEPC PAPISEQQEQ VLTVALGQPV RLCCGRTERG
     RHWYKEGSRL ASAGRVRGWR GRLEIASFLP EDAGRYLCLA RGSMTVVHNL TLIMDDSLPS
     INNEDPKTLS SSSSGHSYLQ QAPYWTHPQR MEKKLHAVPA GNTVKFRCPA AGNPMPTIHW
     LKNGQAFHGE NRIGGIRLRH QHWSLVMESV VPSDRGTYTC LVENSLGSIR YSYLLDVLER
     SPHRPILQAG LPANTTAVVG SNVELLCKVY SDAQPHIQWL KHIVINGSSF GADGFPYVQV
     LKTTDINSSE VEVLYLRNVS AEDAGEYTCL AGNSIGLSYQ SAWLTVLPAE EEDLAWTTAT
     SEARYTDIIL YVSGSLALVL LLLLAGVYHR QAIHGHHSRQ PVTVQKLSRF PLARQFSLES
     RSSGKSSLSL VRGVRLSSSG PPLLTGLVSL DLPLDPLWEF PRDRLVLGKP LGEGCFGQVV
     RAEALGMDSS RPDQTSTVAV KMLKDNASDK DLADLISEME MMKLIGRHKN IINLLGVCTQ
     EGPLYVIVEY AAKGNLREFL RARRPPGPDL SPDGPRSSEG PLSFPALVSC AYQVARGMQY
     LESRKCIHRD LAARNVLVTE DDVMKIADFG LARGVHHIDY YKKTSNGRLP VKWMAPEALF
     DRVYTHQSDV WSFGILLWEI FTLGGSPYPG IPVEELFSLL REGHRMERPP NCPSELYGLM
     RECWHAAPSQ RPTFKQLVEA LDKVLLAVSE EYLDLRLTFG PYSPNNGDAS STCSSSDSVF
     SHDPLPLEPS PFPFPEAQTT
//
